|
March 2022
|
Our core team member receives the prestigious "She is - 75 Women in STEAM" recognition!"Apoorva Bedekar, who leads innovation and strategy at Embryyo, was selected amongst 75 other pioneering women in their respective fields for the "She-is" honor. The recognition was announced by the Office of the Principal Scientific Advisor to the Government of India, His Excellency British High Commissioner and the Red Dot Foundation, on the occasion of India's 75th Anniversary of Independence.
|
|
January 22
|
Ongoing collaboration with a leading orthopedic surgeon to develop solutions that improve implantation outcomesThe objective is to build and test a jig for intraoperative measurements of ligament tensions during total knee replacement (TKR) surgeries, thereby reducing post-implantation complications.
|
|
|
June 21
|
Invented a flow-focusing microchip for a leading hematology manufacturerHematology analysis often requires confining the cellular content of a biological specimen into a micro-environment that can provide a continuous laminar flow regime for optical sensing. Our design could also achieve variations in the width of the interrogation spot and least amount of time to reach laminarity and focusing.
|
|
|
February 2021
|
Ongoing collaboration with a Swedish company to develop a sweat-based continuous glucose monitoring wearableThe product is envisioned as a patch that athletes can wear during workouts, collect their sweat, analyze glucose levels and thus provide personalized recommendations of electrolyte intake to achieve peak athletic performance. The collaboration is a "reduction to practice" exercise of a technology in-licensed from University of California San Diego.
|
|
|
November 2020
|
Embryyo selected for Guild Academy's FEMTECH acceleratorGuild Academy along with FemTech Focus co-organized an 8 weeks accelerator aimed at unmet needs in FemTech, a perfect opportunity for us to carve out and test a product strategy catering to menstrual health and wellness.
|
|
|
August 2020
|
Product design upgrades for Medtronic LabsEmbryyo team has been engaged with Medtronic Labs in developing an upgraded version of a screening device within the constraints of the existing form factor and engineering design. The scope of the project includes selection and replacement of essential components in the existing device, demonstrating proof of concept for the revised product, incorporating design changes for assembly and manufacturing and eventual design transfer to manufacturing partners.
|
|
|
June 2020
|
Inventive engineering design for an implantable deviceEmbryyo team invented and demonstrated proof-of-concept of a novel inserter tool for an implantable device for one of the world leaders in med-tech devices for women's health
|
|
Sep 2018 - Ongoing
|
Early-stage R&D and Front-End Innovation with a leading med-tech MNCEmbryyo has been proudly associated with the R&D and innovations group of a Fortune 100 med-tech MNC (top 10 in global revenues), as a technology partner for front-end innovation, early stage technology de-risking, patent generation and proof of concept demonstration for first-of-its-kind medical device ideas.
|
|
October 2018
|
Embryyo wins the 'success story award' at the India International Science Festival (IISF '18)India International Science Festival (IISF) launched in 2015 is a celebration to promote Science and Technology and demonstrate how science could lead India towards a developed nation within a short span of time. The aim is to engage public with science and celebrate the joy of science and show the ways how science, technology, engineering and mathematics (STEM) provide us with the solutions to improve our lives.
Team Embryyo won the 'success story award' for our novel self-expandable non-vascular stent, at the Industry-Academia Interaction Meet at IISF '18. |
|
|
August 2018
|
Embryyo wins the RICH Cancer Innovation ChallengeWe were awarded as one of the 6 winners of the Cancer Innovation Challenge hosted by RICH, the Research and Innovation Circle of Hyderabad. Our novel self-expandable stent for non-vascular stenting applications for malignant lesions was the winning innovation.
More information here - video summary. |
|
|
July 2018
|
Embryyo team selected for the India Innovation Growth Program (IIGP 2.0) Bootcamp at IIMAThe India Innovation Growth Programme (IIGP) 2.0 is a unique tripartite initiative of the Department of Science and Technology (DST), Government of India, Lockheed Martin and Tata Trusts. We were one of the top 50 teams selected from all over the country (over 2000 applicants) for an intense week-long bootcamp at the Indian Institute of Management Ahmedabad, for our innovation in neonatal jaundice diagnostics.
|
|
|
June 2018
|
Embryyo @BIO2018, Boston, MAWe were invited to showcase our solutions for pre-analytical blood sample preparation at the Emerging Innovator's Zone at BIO2018, world's largest convention for the life sciences industry!
|
|
|
April 2018
|
Fighting Superbugs in India: A video story with glimpses of our work on diagnostics and AMRA 10-minutes video story on the rising incidences of anti-microbial resistance and 'superbugs' in India, and the need for better, faster, smarter diagnostic technologies. Embryyo is a winner of the Discovery Award and competing for the coveted Longitude Prize! Special thanks to Nesta, the Longitude Prize team and BIRAC for supporting and showcasing our work!
PODCAST, Video Story |
|
|
October 2017
|
Embryyo selected to pitch at Device Talks, Boston, a premier event for the MedTech communityEmbryyo was one of the finalists to pitch at the 'Collisions of Value' session at DeviceTalks, Boston. We showcased various possibilities based on our microfluidic cell-separation technology.
|
|
|
August 2017
|
Embryyo wins Longitude Prize Discovery Award 2017 from NestaEmbryyo has been selected as one of the 13 winners internationally for the Longitude Prize Discovery Award, from Nesta UK, a seed grant to develop a rapid point-of-care diagnostic test in blood stream infections to help alleviate the burdens of anti-microbial resistance due to misuse of antibiotics
|
|
|
June 2017
|
VentureWell ASPIRE program: Embryyo was selected in the 2017 cohort of healthcare companiesVentureWell, based in Boston, MA is a leading not-for-profit organization on a mission to cultivate a pipeline of inventors, innovators, and entrepreneurs driven to solve the world's biggest challenges and to create lasting impact. Embryyo participated in their week-long investment readiness workshop with enriching interactions with fellow entrepreneurs, mentors-in-residence and the extended ecosystem in Detroit, MI.
|
|
|
April 2017
|
Embryyo featured as a 'Hot Startup' in Economics TimesThe Economics Times, India's leading newspaper, featured Embryyo as a 'hot startup'.
|
|
|
February 2017
|
MIT Technology Review Innovator Under 35 awardOur founder, Nishant Kumar was recognized as the MIT TR India Innovator under 35 by Mint and MIT Technology Review.
|
|
|
November 2016
|
Embryyo wins 2016 CII Innovation Awards from the Confederation of Indian IndustryTop 10 Most Promising Startups award in the Industrial Innovation Category
Best Startup in the Manufacturing Category |
|
|
September 2016
|
Our commitment to UN Every Woman Every Child initiative, accepted!Embryyo is committed to develop novel tools for fetal growth monitoring in an attempt to improve birth outcomes. Our work is proudly supported under the SPARSH scheme of BIRAC (DBT, India).
|
|
|
August 2016
|
2016 Leadership Conference, Rhode Island, USAEmbryyo Bio-Microdevices, a subsidiary company of Embryyo Technologies was selected as the Top 10 finalists globally for the Business Plan Competition held during the Leadership Conference hosted by Indian Institutes of Technology Association of Greater New England (IIT AGNE)
|
|
|
May 2016
|
Embryyo becomes a proud participant of the United Nations Global CompactThe UN Global Compact is the world's largest corporate sustainability initiative - A call to companies to align strategies and operations with universal principles on human rights, labor, environment and anti-corruption, and take actions that advance societal goals.
|
|
April 2016
|
Geneva Health Forum, 2016We are delighted to announce that Embryyo is participating in the forthcoming Geneva Health Forum in Geneva, in a workshop focused on 'Improving access to quality diagnostic tools in LMICs through social innovation'. More information here.
5th Annual University of Massachusetts, Lowell - M2D2 100K Challenge 2016Embryyo was one of the winners and top 18 finalists of the 5th M2D2 (Massachusetts Medical Device Development) 100K Challenge, for novel microfluidic, blood-plasma separation technology for point of care diagnostics. Read more - MedTech Boston, Mintz Levin
|
|
|
March 2016
|
Festival of Innovations, Rashtrapati Bhawan, New Delhi, 2016Selected for 'Innovations in Medical Science and Biotechnology Showcase' during the Festival of Innovations in the Lawns of the President House, hosted by the Indian Council of Medical Research (ICMR)
Also participated in the a round table discussion on 'Policy Dialogue for Uptake of Innovative Technologies for Public Health Use' |
|
|
December 2015
|
Social Innovation in Health Initiative, WHO TDRInvited to participate in Evidence-based Social Innovation Consultation: Re-imagining Healthcare Delivery Systems in the Global South, at Fondation Mérieux in Veyrier-du-Lac (Annecy), France and WHO Headquarters in Geneva, Switzerland
Women Entrepreneur Quest 2015WEQ is a joint initiative of the Anita Borg Institute India (ABI India), the National Science & Technology Entrepreneurship Development Board (NSTEDB) of the Department of Science and Technology (DST), Government of India and the Indo-US Science and Technology Forum to promote women led startups in technology in India. Embryyo is proud to announce that Sonali Tripathy, our Chief Business Officer for Women's Health Business Unit won the Top 6 position at the prestigious event for her work on cervical cancer screening technology for the community.
|
|
|
November 2015
|
Biotechnology Ignition GrantReceived in-principle approval for the Biotechnology Ignition Grant (75000 USD) by BIRAC - Biotechnology Industry Research Assistance Council, a government of India enterprise for indigenous self-expandable stent development
|
|
|
August - November 2015
|
Intel - DST Innovate for Digital India ChallengeEmbryyo emerged as the TOP 10 teams in the country for our indigenously developed imaging based device for cervical cancer screening in the community. The Intel DST Innovate for Digital India program was hosted by the Center of Innovation Incubation and Entrepreneurship (CIIE) at the Indian Institute of Management Ahmedabad. The program included a 3 months accelerator program by CIIE at IIMA and Lester Center for Entrepreneurship at the University of California Berkeley and a grant award of 10,000 USD. Read more - NDTV Gadgets 360.
|
|
|
October 2015
|
Grand Challenges Meeting 2015, BeijingEmbryyo was invited at the annual Grand Challenges Meeting in Beijing China, to present our ongoing work on neonatal brain growth monitoring.
|
|
|
September 2015
|
Every Woman Every Child Global Strategy Launch, UN Headquarters, New York
|
|
|
July 2015
|
Now, practice of awarding prizes to spur innovation makes its way to IndiaEmbryyo featured on Economics Times.
|
|
|
April 2015
|
Grand Challenges ExplorationsAwarded the prestigious Grand Challenges Explorations Round 14 grant-in-aid of USD 100,000 to develop a novel technology for neonatal brain growth monitoring. One of the top 55 teams globally to receive the award
|
|
|
January 2015
|
Grand Challenges in TB Control - Phase 2Awarded a Phase 2 grant of USD 100,000 under the Grand Challenges in TB Control In India program to conduct a multi-center field trial of the technology developed for drug adherence monitoring in TB patients. One of the top 4 awardees in the country.
|
|
|
December 2014
|
Social Innovation Program for Products Affordable and Relevant to Societal HealthReceived grant award (60000 USD) from BIRAC - Biotechnology Industry Research Assistance Council, a government of India enterprise for novel fetal growth monitoring techniques under the SPARSH scheme.
|
|
|
July 2014
|
Grand Challenges in TB Control - Phase 1Awarded the Grand Challenges in TB Control Phase 1 grant prize of USD 30, 000 from IKP Knowledge Park, supported by the Bill and Melinda Gates Foundation and USAID. One of the top 14 recipients in the country to solve the problem of ‘Drug adherence monitoring in TB patients in India’.
CAMTECH medical technology 'Jugaad-a-thon'Won the 1st Runner’s up position at Jugaad-a-thon, a medical technology hackathon hosted by GE Healthcare in Bangalore, organized by CAMTECH – Consortium of Affordable Medical Technologies based at the Massachusetts General Hospital, Boston
|
|
|
February 2014
|
Embryyo incorporated!Embryyo Technologies registered as a private limited entity under Companies Act, 1956 in Pune, India.
|
|
|
November 2013
|
Embryyo incubated
|
|